MBNL1 rs182314334: Prostate Cancer Risk Stratification
The rs182314334 variant is a genetic change located within the MBNL1 gene. It has been identified in research as a potential marker to help improve the risk stratification of clinically significant prostate cancer.
What each genotype means
Typical risk profile
This genotype represents the common genetic background for this variant. Current research indicates that this variant is used in statistical models to help refine risk stratification for prostate cancer, but carrying this specific genotype does not imply a diagnosis or a definitive change in individual risk. Please consult with a healthcare provider to discuss your overall prostate health and appropriate screening schedules.
This genotype is common in the general population, though specific frequency data for this variant is not widely documented across all ancestries.
Typical risk profile
This genotype represents a heterozygous state for this variant. Research suggests this marker is associated with prostate cancer risk stratification models, but it is not a diagnostic indicator on its own. You should discuss your family history and personal health factors with your clinician to determine if additional prostate cancer screening is appropriate for you.
This genotype is observed in the general population, though specific frequency data for this variant is not widely documented across all ancestries.
Typical risk profile
This genotype represents the alternative state for this variant. While this marker has been identified in studies to improve the statistical accuracy of prostate cancer risk models, it does not serve as a standalone predictor of disease. Please speak with your doctor or a genetic counselor to understand how your personal health history relates to your prostate cancer risk profile.
This genotype is observed in the general population, though specific frequency data for this variant is not widely documented across all ancestries.
What is rs182314334?
The rs182314334 variant is a single nucleotide polymorphism (SNP) located within the MBNL1 gene. In genetics, a SNP represents a variation at a single position in a DNA sequence. This specific variant is classified as intronic, meaning it resides within an intron—a non-coding region of the gene that is removed during the process of creating a functional protein. While intronic variants do not change the protein sequence directly, they can influence how genes are regulated, spliced, or expressed. Researchers often study these variants to understand how subtle differences in non-coding DNA might contribute to complex health traits or disease susceptibility.
The Role of the MBNL1 Gene
The MBNL1 gene encodes the Muscleblind-like 1 protein, which is a key regulator of alternative splicing. Alternative splicing is a cellular process that allows a single gene to produce multiple different protein versions, which is essential for normal development and tissue function. In the context of prostate health, research has shown that MBNL1 and its associated long non-coding RNA (MBNL1-AS1) play complex roles in tumor progression. Studies indicate that MBNL1 expression is often altered in prostate cancer tissues, where it may influence cell proliferation, migration, and the ability of cancer cells to survive. Because MBNL1 helps control the 'instructions' for cell behavior, its dysregulation is a subject of significant interest in oncology research.
Research and Evidence Strength
The association between rs182314334 and prostate cancer is based on statistical modeling, specifically using LASSO-regularized regression. This machine learning technique is used to select a subset of genetic markers that best predict a specific outcome, such as the presence of clinically significant prostate cancer. The evidence for this variant is currently considered moderate. While statistical associations have been observed in research cohorts, these findings are intended for risk stratification rather than individual diagnosis. It is important to note that genetic risk factors are only one piece of the puzzle in cancer development, and many environmental and lifestyle factors also contribute to disease risk.
Understanding Your Results
If you have information about your genotype for rs182314334, it is important to understand that this data is for educational purposes only. A genetic association does not mean that an individual will develop a disease, nor does the absence of a variant guarantee protection. Because this variant is used in the context of risk stratification, it is not a diagnostic tool. You cannot use this information to make medical decisions, change your screening schedule, or alter your lifestyle without consulting a healthcare professional. Always discuss any concerns about prostate cancer risk, family history, or screening options with your doctor, who can provide personalized medical advice based on your complete clinical profile.
How common is this variant?
Specific population frequency data for rs182314334 is not currently well-documented in major public databases. Frequency can vary significantly across different ancestral groups.
Frequently asked questions
Does having this variant mean I will get prostate cancer?
No. Genetic variants like rs182314334 are associated with statistical risk, not certainty. Many factors, including age, family history, and lifestyle, play a much larger role in determining your actual risk of developing prostate cancer.
Can I use this SNP to diagnose prostate cancer?
No. This variant is used in research for risk stratification and is not a diagnostic test. Prostate cancer diagnosis requires clinical evaluation, such as PSA testing, physical exams, or biopsies, performed by a medical professional.
Where can I find more information about MBNL1?
You can search for 'MBNL1' on the National Library of Medicine's MedlinePlus Genetics website or the NCBI Gene database. These resources provide comprehensive, peer-reviewed information about gene functions and their roles in human health.
Should I change my prostate cancer screening based on this result?
You should not change your medical care based on a single genetic variant. Always discuss your genetic results and your overall risk profile with your doctor to determine the appropriate screening schedule for you.
Sources & further reading
Educational information only, last refreshed 11/3/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs182314334?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29